OD-OS releases major software update for Navilas 577s

Teltow, Germany – August 3, 2017 – OD-OS, the global leader in the development and commercialization...

OD-OS launches Pre-Planned PRP for its Navilas Laser System

Teltow, Germany – June 27, 2017 – OD-OS, the global leader in the development and commercialization...

Shortening the Laser Photocoagulation Learning Curve With a Navigated System

Mastering this can be challenging for residents, but a navigated laser helps expedite training.By Dr. Bernd Fassbender, Germany
read the article

Compact Navilas® Laser System 577s Receives U.S. FDA Clearance

Introduction of a compact Navilas Laser System to bring the benefits of navigated retina laser into day-to-day clinical routine

Irvine, CA– (December 1, 2016) – OD-OS, the global leader in the development and commercialization...

Navilas® Laser System 577+ Receives U.S. FDA Clearance

Irvine California – February 14, 2015 – OD-OS, the world leader in Navigated Retinal Imaging and...

Navilas 577+ receives the Ophthalmologist Innovation Award 2014

read the article

OD-OS presents novel Yellow 577nm Navilas Laser System with microsecond pulsing option at World Ophthalmic Congress in Tokyo

Teltow, Germany – OD-OS, the world leader in navigated laser therapy for retinal disease management,...

Multicenter Study Announced to Evaluate Novel Combination Therapy for Treatment of Diabetic Macular Edema

TREX-DME Trial to Validate Efficacy and Stability of Treatment with Navilas® Navigated Laser plus Ranibizumab

Teltow, Germany – OD-OS, the world leader in navigated laser therapy for retinal disease management,...

Navilas® Navigated Laser Plus anti-VEGF Combination Therapy for Diabetic Macular Edema Shown to Reduce Retreatment Rates by More Than 50% While Stabilizing Visual Acuity

Study Shows Novel Combination Treatment Superior to Anti-VEGF Therapy Alone

Teltow, Germany – OD-OS, the world leader in navigated laser therapy for retinal disease management,...